Anticancer therapy targeting the apoptotic pathway
Top Cited Papers
- 1 December 2003
- journal article
- review article
- Published by Elsevier in The Lancet Oncology
- Vol. 4 (12) , 721-729
- https://doi.org/10.1016/s1470-2045(03)01277-4
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- The p53 Tumor Suppressor Gene and Nuclear Protein: Basic Science Review and Relevance in the Management of Bladder CancerJournal of Urology, 2003
- Farnesyl transferase inhibitors in the treatment of breast cancerExpert Opinion on Investigational Drugs, 2003
- High-dose therapy and immunomodulatory drugs in multiple myelomaSeminars in Oncology, 2002
- On the TRAIL to apoptosisCytokine & Growth Factor Reviews, 2002
- HtrA2 Promotes Cell Death through Its Serine Protease Activity and Its Ability to Antagonize Inhibitor of Apoptosis ProteinsJournal of Biological Chemistry, 2002
- Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and DeathScience, 2001
- The IAP family: endogenous caspase inhibitors with multiple biological activitiesCell Research, 2000
- Activity of TER286 against human tumor colonyforming unitsAnti-Cancer Drugs, 1997
- The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of ApoptosisScience, 1997
- Structure of Bcl-x L -Bak Peptide Complex: Recognition Between Regulators of ApoptosisScience, 1997